Media organisations ABC and Fairfax have argued that a judge’s definition of espionage was “artificially narrow” when striking out their truth defence to a defamation case brought by Chinese philanthropist Dr Chau Chak Wing.
A female Piper Alderman partner has filed a sex discrimination lawsuit against the firm’s other partners and has won a temporary injunction blocking the partnership from ousting her.
Westpac has been hit with a class action for allegedly breaching responsible lending laws by providing unsuitable loans, the first of the big four banks to face a class action in the wake of the banking royal commission’s scathing final report.
The Construction, Forestry, Maritime, Mining and Energy Union has lost a battle with liquidators for failed labour hire business One Key Workforce over access to $1 million it said was owed in unpaid wages only to its members.
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi’s challenge to a judge’s refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.
The Full Court of the Federal Court has shot down a bid by the Victorian Government to intervene a second time in a long-running bargaining dispute between Esso Australia and three key Australian unions over its Bass Strait offshore oil and gas operations.
The Federal Government failed to read public submissions in approving a “flawed” assessment of a project supplying Adani’s controversial Carmichael coal mine with over 12.5 billion litres of water, an environmental group has told a court.
Generic drug maker Sandoz must pay $26.34 million to Danish pharmacuetical giant Lundbeck and a subsidiary for infringing the Australian patent behind the blockbuster antidepressant Lexapro, a judge has found.
Gladstone Ports has won access to draft expert reports prepared by Clyde & Co in its $100 million class action against the Queensland government owned organisation, with a judge ruling the documents were not privileged despite their not being used in the case.
Drug maker Neurim Pharmaceuticals has won a bid to amend its Australian patent for top selling sleeping pill Circadin over the protests of two generic pharmaceutical companies, whch argued Neurim had purposely delayed the application to gain an unfair advantage in its infringement suit.